Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin
- 27 March 2017
- journal article
- Published by Elsevier BV in Microvascular Research
- Vol. 112, 72-78
- https://doi.org/10.1016/j.mvr.2017.03.007
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 HL-39286-20)
This publication has 73 references indexed in Scilit:
- Heparin and Related Drugs: Beyond Anticoagulant ActivityISRN Pharmacology, 2013
- Shedding of the endothelial glycocalyx in arterioles, capillaries, and venules and its effect on capillary hemodynamics during inflammationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Salt overload damages the glycocalyx sodium barrier of vascular endotheliumPflügers Archiv - European Journal of Physiology, 2011
- Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutesMicrovascular Research, 2010
- Heparanase: busy at the cell surfaceTrends in Biochemical Sciences, 2009
- The Glycocalyx of the Human Umbilical Vein Endothelial CellCirculation Research, 2009
- Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypassPerfusion, 2008
- Heparin Impairs Glycocalyx Barrier Properties and Attenuates Shear Dependent Vasodilation in MiceHypertension, 2007
- The endothelial glycocalyx: composition, functions, and visualizationPflügers Archiv - European Journal of Physiology, 2007
- Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia.The Journal of cell biology, 1989